Kisby, Cassandra K., Anthony Visco, and Cindy Amundsen. “Response to "Intraurethral Lidocaine Use During Urodynamic Testing Deserves Further Study".” Female Pelvic Med Reconstr Surg 26, no. 7 (July 2020): 465. https://doi.org/10.1097/SPV.0000000000000793.
Cindy Louise Amundsen, MD
Roy T. Parker, M.D. Distinguished Professor of Obstetrics and Gynecology, in the School of Medicine
Campus Mail:
5324 McFarland Drive Suite 310, Box 3192, Durham, NC 27617
Phone:
(919) 401-1006
Email:
cindy.amundsen@duke.edu
- Application of nerve stimulation (Interstim therapy) for control of continence
- Evaluation of botox therapy for urinary urge incontinence
- Evaluation and treatment for nocturnal voiding
- Application of nerve stimulation for control of continence and enable proper voiding in individuals with Spinal cord injuries
- Application of nerve stimulation for urinary retention
- Minimally invasive prolapse surgery using graft material for enhancing pelvic organ prolapse repairs
-Treatment for stress urinary incontinence with minimally invasive techniques
- Evaluation of the urinary microbiome as it relates to recurrent urinary tract infections and lower urinary tract symptoms
Education and Training
- Urogynecology Fellowship, Surgery, University of Texas Health Science Center San Antonio, 1995 - 1996
- Residency, Obstetrics & Gynecology, University of Texas Health Science Center San Antonio, 1991 - 1995
- M.D., University of Tennessee Health Science Center, 1991
Certifications
- American Board of Obstetrics and Gynecology, 1997
- Female Pelvic Medicine and Reconstructive Surgery, 2013
Research
Lower Urinary Tract Dysfunction / Pelvic Floor Disorders
Selected Grants and Awards
- Duke Women's Reproductive Health Research Scholars
- Advancing the Measurement and Classification of Lower Urinary Tract Dysfunction
- AUGS/DUKE Urogynecology Clinical Research Educational Scientist Training (UrogynCREST) Program
- A prospective study to assess the efficacy and safety of the BlueWind RENOVA iStim System in the treatment of patients diagnosed with overactive bladder (OASIS - OverActive bladder StImulation System
- Predicting Urinary Continence Status with Sacral Neuromodulation and Botulinum Toxin Treatments
- Duke KURe Program - Supplement
- Underactive Bladder: Mechanisms and Recovery of Sensation and Function
- Building Interdisciplinary Research Careers in Women's Health
- Duke University Medical Center (DUMC) Pelvic Floor Disorders Network (PFDN) Clinical Site
- Effects of Aging and the Urinary Microbiome on Recurrent Urinary Tract Infections
- Model for Predicting Efficacy of Treatment and Complications in Women after Intradetrusor OnabotulinumtoxinA for Non-Neurogenic Urgency Incontinence"
- Epigenomics in insulin resistance associated overactive bladder
- Neural Prosthetic Control of Continence and Micturition
- Combination Therapy in the Treatment of Urge Urinary Incontinence: A Randomized, Placebo Controlled Trial
- Symptoms of Lower Urinary Tract Dysfunction Research Network (U01) Supplement
- The Jahnigen Career Development Award (JCDA)
- Nocturnal Deterusor Overactivity In Overactive Bladder Syndrome
- The Effect of Androgens on Sexual Function in Women with Polycystic Ovarian Syndrome
Publications
Harvie, Heidi S., Cindy L. Amundsen, Simon J. Neuwahl, Amanda A. Honeycutt, Emily S. Lukacz, Vivian W. Sung, Rebecca G. Rogers, et al. “Cost-Effectiveness of Sacral Neuromodulation versus OnabotulinumtoxinA for Refractory Urgency Urinary Incontinence: Results of the ROSETTA Randomized Trial.” J Urol 203, no. 5 (May 2020): 969–77. https://doi.org/10.1097/JU.0000000000000656.
Harvie, Heidi S., Cindy L. Amundsen, Simon J. Neuwahl, Amanda A. Honeycutt, Emily S. Lukacz, Vivian W. Sung, Rebecca G. Rogers, et al. “Reply by Authors.” J Urol 203, no. 5 (May 2020): 977. https://doi.org/10.1097/JU.0000000000000656.02.
Gill, Bradley, Cindy L. Amundsen, Sonia Thomas, Lindsey Barden, Ariana Smith, Yuko Komesu, and J Eric Jelovsek. “INTRAOPERATIVE PREDICTORS OF SACRAL NEUROMODULATION IMPLANTATION & TREATMENT RESPONSE - RESULTS FROM THE ROSETTA TRIAL.” In Journal of Urology, 203:E1020–21. LIPPINCOTT WILLIAMS & WILKINS, 2020.
Clemens, J Quentin, Jonathan B. Wiseman, Abigail R. Smith, Cindy L. Amundsen, Claire C. Yang, Megan S. Bradley, Ziya Kirkali, Nnenaya Q. Agochukwu, Anne P. Cameron, and Anne P. LURN Study Group. “Prevalence, subtypes, and correlates of nocturia in the symptoms of Lower Urinary Tract Dysfunction Research Network cohort.” Neurourol Urodyn 39, no. 4 (April 2020): 1098–1107. https://doi.org/10.1002/nau.24338.
Amundsen, Cindy L., Margaret E. Helmuth, Abigail R. Smith, John O. L. DeLancey, Catherine S. Bradley, Kathryn E. Flynn, Kimberly S. Kenton, et al. “Longitudinal changes in symptom-based female and male LUTS clusters.” Neurourol Urodyn 39, no. 1 (January 2020): 393–402. https://doi.org/10.1002/nau.24219.
VanDusen, Keith W., Sarada Eleswarpu, Eugene W. Moretti, Michael J. Devinney, Donna M. Crabtree, Daniel T. Laskowitz, Marty G. Woldorff, et al. “The MARBLE Study Protocol: Modulating ApoE Signaling to Reduce Brain Inflammation, DeLirium, and PostopErative Cognitive Dysfunction.” J Alzheimers Dis 75, no. 4 (2020): 1319–28. https://doi.org/10.3233/JAD-191185.
Cameron, Anne P., Jonathan B. Wiseman, Abigail R. Smith, Robert M. Merion, Brenda W. Gillespie, Catherine S. Bradley, Cindy L. Amundsen, et al. “Are three-day voiding diaries feasible and reliable? Results from the Symptoms of Lower Urinary Tract Dysfunction Research Network (LURN) cohort.” Neurourol Urodyn 38, no. 8 (November 2019): 2185–93. https://doi.org/10.1002/nau.24113.
McKee, Dana C., Eric J. Gonzalez, Cindy L. Amundsen, and Warren M. Grill. “Randomized Controlled Trial to Assess the Impact of High Concentration Intraurethral Lidocaine on Urodynamic Voiding Parameters.” Urology 133 (November 2019): 72–77. https://doi.org/10.1016/j.urology.2019.08.020.
Andy, Uduak U., Cindy L. Amundsen, Emily Honeycutt, Alayne D. Markland, Gena Dunivan, Keisha Y. Dyer, Nicole B. Korbly, et al. “Sacral neuromodulation versus onabotulinumtoxinA for refractory urgency urinary incontinence: impact on fecal incontinence symptoms and sexual function.” Am J Obstet Gynecol 221, no. 5 (November 2019): 513.e1-513.e15. https://doi.org/10.1016/j.ajog.2019.06.018.